This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pharma Mar, S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Inventor Núria Bayó-Puxan: Pioneering Antitumoral Compounds
Introduction
Núria Bayó-Puxan is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral compounds. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
Núria Bayó-Puxan holds a patent for antitumoral compounds, specifically those of Formula I, along with pharmaceutically acceptable salts, derivatives, tautomers, prodrugs, or stereoisomers that are useful as antitumor agents. This patent represents a significant advancement in the search for effective cancer therapies. He has 1 patent to his name.
Career Highlights
Núria is currently associated with Pharma Mar, S.A., a company known for its focus on developing innovative medicines for cancer treatment. His work at Pharma Mar has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Núria has collaborated with esteemed colleagues, including Judit Tulla-Puche and Eleonora Marcucci. These collaborations have fostered a productive environment for innovation and research in the field of oncology.
Conclusion
Núria Bayó-Puxan's contributions to the development of antitumoral compounds highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile